JPWO2022045336A1 - - Google Patents

Info

Publication number
JPWO2022045336A1
JPWO2022045336A1 JP2022545758A JP2022545758A JPWO2022045336A1 JP WO2022045336 A1 JPWO2022045336 A1 JP WO2022045336A1 JP 2022545758 A JP2022545758 A JP 2022545758A JP 2022545758 A JP2022545758 A JP 2022545758A JP WO2022045336 A1 JPWO2022045336 A1 JP WO2022045336A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022545758A
Other languages
Japanese (ja)
Other versions
JPWO2022045336A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022045336A1 publication Critical patent/JPWO2022045336A1/ja
Publication of JPWO2022045336A5 publication Critical patent/JPWO2022045336A5/ja
Priority to JP2026072614A priority Critical patent/JP2026126306A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022545758A 2020-08-31 2021-08-30 Pending JPWO2022045336A1 (cg-RX-API-DMAC7.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026072614A JP2026126306A (ja) 2020-08-31 2026-04-24 パーキンソン病の運動合併症治療薬

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020145967 2020-08-31
PCT/JP2021/031722 WO2022045336A1 (ja) 2020-08-31 2021-08-30 パーキンソン病の運動合併症治療薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026072614A Division JP2026126306A (ja) 2020-08-31 2026-04-24 パーキンソン病の運動合併症治療薬

Publications (2)

Publication Number Publication Date
JPWO2022045336A1 true JPWO2022045336A1 (cg-RX-API-DMAC7.html) 2022-03-03
JPWO2022045336A5 JPWO2022045336A5 (cg-RX-API-DMAC7.html) 2024-09-04

Family

ID=80353469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022545758A Pending JPWO2022045336A1 (cg-RX-API-DMAC7.html) 2020-08-31 2021-08-30
JP2026072614A Pending JP2026126306A (ja) 2020-08-31 2026-04-24 パーキンソン病の運動合併症治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026072614A Pending JP2026126306A (ja) 2020-08-31 2026-04-24 パーキンソン病の運動合併症治療薬

Country Status (10)

Country Link
US (2) US11628169B2 (cg-RX-API-DMAC7.html)
EP (1) EP4218764A4 (cg-RX-API-DMAC7.html)
JP (2) JPWO2022045336A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230058615A (cg-RX-API-DMAC7.html)
CN (1) CN116113402A (cg-RX-API-DMAC7.html)
AU (1) AU2021332775A1 (cg-RX-API-DMAC7.html)
CA (1) CA3189670A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023002422A (cg-RX-API-DMAC7.html)
TW (1) TW202227080A (cg-RX-API-DMAC7.html)
WO (1) WO2022045336A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3168199A1 (en) 2020-02-19 2021-08-26 Eri ICHIBAYASHI Transdermal absorption preparation
JPWO2022045336A1 (cg-RX-API-DMAC7.html) * 2020-08-31 2022-03-03

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228414A (ja) * 1998-02-06 1999-08-24 Sumitomo Pharmaceut Co Ltd タンドスピロン経皮剤
JPH11228454A (ja) * 1998-02-17 1999-08-24 Sumitomo Chem Co Ltd アルキニル置換アリールブロミド類の製造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507303A (en) 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
JPS58126865A (ja) 1981-12-22 1983-07-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
JP2002020291A (ja) 2000-06-30 2002-01-23 Sumitomo Pharmaceut Co Ltd 認知機能障害の治療剤
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
WO2005117886A1 (ja) 2004-06-01 2005-12-15 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
ATE413166T1 (de) 2004-11-22 2008-11-15 Hisamitsu Pharmaceutical Co Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff
JP4873871B2 (ja) 2005-02-28 2012-02-08 久光製薬株式会社 粘着剤及び貼付剤
WO2008044336A1 (en) 2006-10-11 2008-04-17 Hisamitsu Pharmaceutical Co., Inc. Crystal-containing adhesive preparation
EP2729176A1 (en) 2011-07-05 2014-05-14 Contera Pharma APS The use of serotonin receptor agonists for treatment of movement disorders
MY169068A (en) 2012-04-18 2019-02-12 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
EP3897641B1 (en) * 2018-12-20 2023-11-15 Contera Pharma A/S Treatment of movement disorders
JP2020145967A (ja) 2019-03-13 2020-09-17 日清食品ホールディングス株式会社 プライマー及び特定昆虫の検出方法
US10758535B1 (en) 2019-04-26 2020-09-01 Sumitomo Dainippon Pharma Co., Ltd. Therapeutic drug for dyskinesia
CA3168199A1 (en) 2020-02-19 2021-08-26 Eri ICHIBAYASHI Transdermal absorption preparation
JPWO2022045336A1 (cg-RX-API-DMAC7.html) * 2020-08-31 2022-03-03

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228414A (ja) * 1998-02-06 1999-08-24 Sumitomo Pharmaceut Co Ltd タンドスピロン経皮剤
JPH11228454A (ja) * 1998-02-17 1999-08-24 Sumitomo Chem Co Ltd アルキニル置換アリールブロミド類の製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADVANCES IN NEUROREGULATION AND NEUROPROTECTION, JPN6025038079, 2005, pages 369 - 378, ISSN: 0005687829 *
精神科治療学, vol. 14, no. 11, JPN6025038078, 1999, pages 1271 - 1274, ISSN: 0005787045 *

Also Published As

Publication number Publication date
US11628169B2 (en) 2023-04-18
JP2026126306A (ja) 2026-08-04
EP4218764A1 (en) 2023-08-02
WO2022045336A1 (ja) 2022-03-03
US20220062282A1 (en) 2022-03-03
US20230241062A1 (en) 2023-08-03
AU2021332775A9 (en) 2024-09-26
CA3189670A1 (en) 2022-03-03
MX2023002422A (es) 2023-03-22
AU2021332775A1 (en) 2023-04-27
EP4218764A4 (en) 2024-10-02
KR20230058615A (ko) 2023-05-03
CN116113402A (zh) 2023-05-12
TW202227080A (zh) 2022-07-16

Similar Documents

Publication Publication Date Title
BR112023016752B1 (pt) Sistema de drenagem a vácuo
CN305839914S (zh) 多功能调奶器(mt503)
CN305816923S (zh) 水槽碗碟架(3)
CN305823596S (zh) 电子烟(NordX)
CN305789036S (zh) 中控机外壳
CN305790533S (zh) 墙壁插座
CN305694986S (zh) 花生酱料盒
CN305694542S (zh) 餐垫(三叶草)
CN305674685S (zh) 袜子(3)
CN305671434S (zh) 陶瓷水盂(青花缠枝莲芭蕉纹)
CN305703963S (zh) 鼠脑组织切割装置
CN305676320S (zh) 盘子(古琳琅)
CN305673038S (zh) 球泡灯(带扣)
CN305814728S (zh) 大衣(水貂内胆)
CN305699801S (zh) 槽形轨道型材
CN305672356S (zh) 浴室置物架(b款)
CN305674003S (zh) 烫发器(9)
CN305704889S (zh) 培根肉包装袋
CN305700685S (zh) 电子烟(s600)
CN305696886S (zh) 汽车龙门架
CN305670763S (zh) 潜水泵
CN305535016S (zh) 折叠瓷砖倒角架
CN305566477S (zh) 包装袋袋口卷边机(ⅰ)
CN305557501S (zh) 组合柜套件
CN305808962S (zh) 玩具车用轨道

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230728

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240827

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250916

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251023

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260424